Gene amplification and tumor grading in parosteal osteosarcoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Parosteal osteosarcoma (POS) is a low-grade osteosarcoma.
• MDM2 and CDK4 oncogenes are amplified in POS.
• POS typically behaves indolently but can progress to a fatal high-grade form.

Purpose of the Study:

• To investigate the relationship between MDM2/CDK4 gene amplification and tumor grading in POS.
• To determine if gene amplification can predict the aggressiveness and metastatic potential of POS.

Main Methods:

• Retrospective analysis of 40 tumor specimens from 14 recurrent POS patients.
• Utilized immunostaining, multiplex quantitative polymerase chain reaction (MQPCR), and fluorescence in situ hybridization (FISH) to assess MDM2/CDK4 expression and amplification.
• Compared findings between low-grade and high-grade POS specimens.

Main Results:

• All POS cases exhibited increased MDM2 and CDK4 protein expression.
• MQPCR and FISH confirmed marked increases in MDM2 and CDK4 gene copies in most POS.
• Amplification levels increased with tumor progression, with higher folds in high-grade POS compared to conventional osteosarcoma.

Conclusions:

• FISH and MQPCR are effective for assessing oncogene amplification in bone tumors.
• MDM2 and CDK4 amplification levels are directly related to POS tumor grading and progression.
• Molecular determination of gene amplification offers a reliable method for predicting POS clinical behavior from small biopsies.